| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/03/1998 | CN1183770A Piperazine derivs, medicaments contg. same, their use and process for preparing same |
| 06/03/1998 | CN1183769A Alpha -(substd. alkylphenyl) -4 -(hydroxy -diphenylmethyl) -1 -piperidine butanol derivs., their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators |
| 06/03/1998 | CN1183768A Benzyl piepridine derivs as pharmaceutical agents |
| 06/03/1998 | CN1183767A Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/03/1998 | CN1183766A Selective thrombin inhibitors |
| 06/03/1998 | CN1183765A Phenoxyethyamine derivs. having high affinity for 5 -HT1A receptor, preparation thereof, use thereof as drugs, and pharmaceutical composition contg. said derivs |
| 06/03/1998 | CN1183763A Tetralines bearing phenyl substituant on aromatic ring and their use in treatment of epilepsy, stroke and brain or spinal trauma |
| 06/03/1998 | CN1183726A Synthetic cryptophycins |
| 06/03/1998 | CN1183723A Transdermal therapeutic system for administering testosterone |
| 06/03/1998 | CN1183722A Use of penciclovir for treatment of human herpes-virus-8 |
| 06/03/1998 | CN1183721A Pharmaceutical composition contg. tiagabine hydrochloride and process for its preparation |
| 06/03/1998 | CN1183720A Method for treatment of macular degeneration |
| 06/03/1998 | CN1183719A Use of imidazo £1, 2-a| pyridine -3 -acetamide derivs. for therapeutic treatment of neuropsychiatric syndromes associated with disfunction of neural circuits of basal ganglia |
| 06/03/1998 | CN1183718A Pharmacological use of certain cystine derivs. |
| 06/03/1998 | CN1183717A Use of R-NSAID in protective composition for treatment of colorectal cancer |
| 06/03/1998 | CN1183716A Multiple unit effervescent dosage forms comprising protonpump inhibitor |
| 06/03/1998 | CN1183475A Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same |
| 06/03/1998 | CN1183414A S type 2 -substituted hydroxy-2 -indolidinylbutyric ester compounds and process for preparation thereof |
| 06/03/1998 | CN1183413A Thiazolidine derivative and its use for making medicanients |
| 06/03/1998 | CN1183412A New benzopyran compounds, process for preparating them and pharmaceutical compositions containing them |
| 06/03/1998 | CN1183302A Eye drops contg. sodium hyaluronate and preparing method thereof |
| 06/03/1998 | CN1183287A Paste for treating spur |
| 06/03/1998 | CN1183281A Ointment contg. low-molecular heparin and its preparing method |
| 06/03/1998 | CN1183278A Nucleic acid oral liquid and its preparing method |
| 06/03/1998 | CN1183276A Pharmaceutical compositions containing thiazolidine derivative and preparation process thereof |
| 06/03/1998 | CN1183275A Use of thiazolidine derivative for making medicaments |
| 06/03/1998 | CN1183274A Bismuth lactate complexes, compound preparations composed of antihistaminic and preparation thereof |
| 06/03/1998 | CN1038592C 2', 5' -oligoadenylate derivs. and pharmeceutical composition contg. same |
| 06/03/1998 | CN1038591C Processes for diastereoselective synthesis of nucleosides |
| 06/03/1998 | CN1038590C Process for preparing platinum complex |
| 06/03/1998 | CN1038589C Process for preparing 7 -acyl -3 -(substd. carbamyloxy) cephen compound |
| 06/03/1998 | CN1038588C Process for preparing 4 £4 -£4 -£4 -££2 -(2, 4 -difluorophenyl) -2 -(1H -azolylmethyl) -1, 3 -dioxlan -4 -yl| methox| phenyl| -1 -piperazinyl| phenyl| triazolones |
| 06/03/1998 | CN1038587C Process for preparation of 1, 4 -dihydropyridine derivs. |
| 06/03/1998 | CN1038586C Process for preparing pyrazine derivs |
| 06/03/1998 | CN1038585C Process for preparation of 2, 4 - and 2, 5 -substd. pyridine -N -oxides |
| 06/03/1998 | CN1038582C Benzene deriv. useful for ischemic diseases |
| 06/03/1998 | CN1038557C Diazoletan effervescent tablets and preparing method thereof |
| 06/03/1998 | CA2223349A1 Use of lower alkanoyl l-carnitines to produce a medicament suitable for the therapeutic treatment of retinopathies |
| 06/03/1998 | CA2223149A1 Highly fermentable resistant starch |
| 06/02/1998 | US5760276 Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
| 06/02/1998 | US5760260 Cosmetics, oxidation resistance and tasteless compounds for lipsticks |
| 06/02/1998 | US5760259 Myristic acid derivatives capable of inhibiting biosynthesis of parasite's anchoring group |
| 06/02/1998 | US5760248 Having improved metabolic stability |
| 06/02/1998 | US5760245 Homochiral intermediates for preparation of orally active azole derivatives |
| 06/02/1998 | US5760233 Chemical intermediates for making erythromycins antibiotics |
| 06/02/1998 | US5760225 Certain pyrazole derivatives as corticotropin-releasing factor receptor CRF1 specific ligands |
| 06/02/1998 | US5760224 Antidepressants for treating psychological disorders |
| 06/02/1998 | US5760214 Bone resorption inhibition/osteogenesis promotion compound |
| 06/02/1998 | US5760213 Immunoactivating agent |
| 06/02/1998 | US5760092 Allocolchinones and uses thereof |
| 06/02/1998 | US5760090 Method for treating asthma using optically pure R(-) albuterol |
| 06/02/1998 | US5760087 Glycylanilide derivatives, their preparation and their application in therapy |
| 06/02/1998 | US5760086 Nasal administration of agents for treatment of delayed onset emesis |
| 06/02/1998 | US5760085 Decongestants |
| 06/02/1998 | US5760084 Treating dermatological disorders |
| 06/02/1998 | US5760083 Use of CLA to reduce the incidence of valgus and varus leg deforomities in poultry |
| 06/02/1998 | US5760082 Dietetic foods containing conjugated linoleic acids |
| 06/02/1998 | US5760081 Eicosapentaenoic and(or) docosahexaenoic acid |
| 06/02/1998 | US5760077 Local anesthetic in subanesthetic concentration |
| 06/02/1998 | US5760076 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 06/02/1998 | US5760075 Method and means for prevention and treatment of secondary cataract |
| 06/02/1998 | US5760074 Central nervous system disorders |
| 06/02/1998 | US5760073 Treatment of central nervous system disorders |
| 06/02/1998 | US5760072 Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
| 06/02/1998 | US5760071 An urea or thiourea compounds for treating melatoninergic system disorder, sleep disorder |
| 06/02/1998 | US5760069 Method of treatment for decreasing mortality resulting from congestive heart failure |
| 06/02/1998 | US5760068 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |
| 06/02/1998 | US5760065 Anti-HIV agent |
| 06/02/1998 | US5760064 Sulfonylalkanoylamino hydroxyethylamino sulfanamides useful as retroviral protease inhibitors |
| 06/02/1998 | US5760061 Using a benzothiophene compound |
| 06/02/1998 | US5760060 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism |
| 06/02/1998 | US5760059 Indole derivatives |
| 06/02/1998 | US5760057 Anticoagulants |
| 06/02/1998 | US5760056 Treatment of psychological disorders with chloroquinoline of pyrazolinecarboxamide derivatives of adamantane carboxylic acids |
| 06/02/1998 | US5760055 Biologically active tropane derivatives |
| 06/02/1998 | US5760054 Alpha IC adrenergic receptor antagonists |
| 06/02/1998 | US5760052 Composition for use as a fungistat and for the treatment of fungal infections |
| 06/02/1998 | US5760051 Central nervous system |
| 06/02/1998 | US5760050 Schizophrenia |
| 06/02/1998 | US5760049 Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use |
| 06/02/1998 | US5760047 Method for treatment of obesity using prolactin modulators and diet |
| 06/02/1998 | US5760046 oral low daily dosage of FINASTERIDE; treating female hirsutism; promoting hair growth; hyperandrogenic conditions of acne vulgaris, seborrhea, polycystic ovary syndrome |
| 06/02/1998 | US5760045 Delta-17 and delta-20 olefinic and saturated 17β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors useful in the prevention and treatment of hyperandrogenic disorders |
| 06/02/1998 | US5760044 Method for treating cocaine and amphetamine dependency |
| 06/02/1998 | US5760043 Process for retarding hair loss and for inducing and stimulating its growth |
| 06/02/1998 | US5760041 4-aminoquinazoline EGFR Inhibitors |
| 06/02/1998 | US5760039 Lyophilized composition containing S(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione) |
| 06/02/1998 | US5760038 Substituted biphenyl sulfonamide endothelin antagonists |
| 06/02/1998 | US5760037 Derivatives of N'N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene diamine and the use thereof in pharmaceutical and cosmetic compostions |
| 06/02/1998 | US5760036 Enzyme inhibitors of retroviral protease for prevention of aids |
| 06/02/1998 | US5760035 Piperidine compounds substituted with an aminoalkyl group and an aryloxyalkyl group, antiallergens, antiinflammatory agents, immunosuppressants |
| 06/02/1998 | US5760027 Use of 7-alkylidene cephalosporins to inhibit elastase activity |
| 06/02/1998 | US5760025 Administering testosterone 5a-reductase inhibitors |
| 06/02/1998 | US5760024 Using cyclooxygenase inhibitors such as aspirin to promote embryo implantation |
| 06/02/1998 | US5760023 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| 06/02/1998 | US5760022 Pharmaceutical composition with improved bioavailability of inositol phosphate |
| 06/02/1998 | US5760021 Treating or preventing metabolic bone disorders |
| 06/02/1998 | US5760020 Lipid emulsion |
| 06/02/1998 | US5760019 Inhibit protease enzymes |
| 06/02/1998 | US5760018 Treatment of pain, inflammation, migraine, emesis |